PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma
Gespeichert in:
| Veröffentlicht in: | European journal of nuclear medicine and molecular imaging 2020-08, Vol.47 (9), p.2216-2217 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2217 |
|---|---|
| container_issue | 9 |
| container_start_page | 2216 |
| container_title | European journal of nuclear medicine and molecular imaging |
| container_volume | 47 |
| creator | Mittlmeier, L. M. Unterrainer, M. Todica, A. Cyran, C. C. Rodler, S. Bartenstein, P. Stief, C. G. Ilhan, H. Staehler, M. |
| description | |
| doi_str_mv | 10.1007/s00259-019-04636-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2336256747</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2336256747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-7a24fa2b6cfe4d37e3f8bce086fbbfae59fbec16090a3e1516ff38adabf77c0d3</originalsourceid><addsrcrecordid>eNp9kDtPwzAQgC0EoqXwBxhQJBaWUD8SOxmrqjwkEJUoYrQc9wwuTVLsZOi_xyGlSAwM9p3t786nD6Fzgq8JxmLsMaZpHmMSVsIZj_kBGhIejgJn-eE-F3iATrxfYUwymuXHaMBITtMkzYbodf78OInms8V4uohM7aJm62pvK4g_bKU8RLZ6t4VtwktZV1201Vu4jEpolG9UY3XkoFLrSMM6bMppW9WlOkVHRq09nO3iCL3czBbTu_jh6fZ-OnmINRNpEwtFE6NowbWBZMkEMJMVGnDGTVEYBWluCtCE4xwrBiQl3BiWqaUqjBAaL9kIXfV9N67-bME3srS-G0VVULdeUsY4TblIREAv_6CrunVh9EAlFDOWUk4CRXtKBw_egZEbZ0vltpJg2WmXvXYZtMtv7ZKHootd67YoYbkv-fEcANYDftMJBPf79z9tvwCbvI4z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2420335261</pqid></control><display><type>article</type><title>PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Mittlmeier, L. M. ; Unterrainer, M. ; Todica, A. ; Cyran, C. C. ; Rodler, S. ; Bartenstein, P. ; Stief, C. G. ; Ilhan, H. ; Staehler, M.</creator><creatorcontrib>Mittlmeier, L. M. ; Unterrainer, M. ; Todica, A. ; Cyran, C. C. ; Rodler, S. ; Bartenstein, P. ; Stief, C. G. ; Ilhan, H. ; Staehler, M.</creatorcontrib><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-019-04636-6</identifier><identifier>PMID: 31925458</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Carcinoma, Renal Cell - diagnostic imaging ; Carcinoma, Renal Cell - drug therapy ; Cardiology ; Edetic Acid ; Enzyme inhibitors ; Glutamate Carboxypeptidase II ; Humans ; Image of the Month ; Imaging ; Kidney cancer ; Kidney Neoplasms - diagnostic imaging ; Kidney Neoplasms - drug therapy ; Kinases ; Male ; Medicine ; Medicine & Public Health ; Metastases ; Nuclear Medicine ; Oncology ; Orthopedics ; Positron Emission Tomography Computed Tomography ; Prostatic Neoplasms ; Radiology ; Renal cell carcinoma ; Tyrosine</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2020-08, Vol.47 (9), p.2216-2217</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-7a24fa2b6cfe4d37e3f8bce086fbbfae59fbec16090a3e1516ff38adabf77c0d3</citedby><cites>FETCH-LOGICAL-c375t-7a24fa2b6cfe4d37e3f8bce086fbbfae59fbec16090a3e1516ff38adabf77c0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00259-019-04636-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00259-019-04636-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31925458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mittlmeier, L. M.</creatorcontrib><creatorcontrib>Unterrainer, M.</creatorcontrib><creatorcontrib>Todica, A.</creatorcontrib><creatorcontrib>Cyran, C. C.</creatorcontrib><creatorcontrib>Rodler, S.</creatorcontrib><creatorcontrib>Bartenstein, P.</creatorcontrib><creatorcontrib>Stief, C. G.</creatorcontrib><creatorcontrib>Ilhan, H.</creatorcontrib><creatorcontrib>Staehler, M.</creatorcontrib><title>PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><subject>Carcinoma, Renal Cell - diagnostic imaging</subject><subject>Carcinoma, Renal Cell - drug therapy</subject><subject>Cardiology</subject><subject>Edetic Acid</subject><subject>Enzyme inhibitors</subject><subject>Glutamate Carboxypeptidase II</subject><subject>Humans</subject><subject>Image of the Month</subject><subject>Imaging</subject><subject>Kidney cancer</subject><subject>Kidney Neoplasms - diagnostic imaging</subject><subject>Kidney Neoplasms - drug therapy</subject><subject>Kinases</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastases</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Orthopedics</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Prostatic Neoplasms</subject><subject>Radiology</subject><subject>Renal cell carcinoma</subject><subject>Tyrosine</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kDtPwzAQgC0EoqXwBxhQJBaWUD8SOxmrqjwkEJUoYrQc9wwuTVLsZOi_xyGlSAwM9p3t786nD6Fzgq8JxmLsMaZpHmMSVsIZj_kBGhIejgJn-eE-F3iATrxfYUwymuXHaMBITtMkzYbodf78OInms8V4uohM7aJm62pvK4g_bKU8RLZ6t4VtwktZV1201Vu4jEpolG9UY3XkoFLrSMM6bMppW9WlOkVHRq09nO3iCL3czBbTu_jh6fZ-OnmINRNpEwtFE6NowbWBZMkEMJMVGnDGTVEYBWluCtCE4xwrBiQl3BiWqaUqjBAaL9kIXfV9N67-bME3srS-G0VVULdeUsY4TblIREAv_6CrunVh9EAlFDOWUk4CRXtKBw_egZEbZ0vltpJg2WmXvXYZtMtv7ZKHootd67YoYbkv-fEcANYDftMJBPf79z9tvwCbvI4z</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Mittlmeier, L. M.</creator><creator>Unterrainer, M.</creator><creator>Todica, A.</creator><creator>Cyran, C. C.</creator><creator>Rodler, S.</creator><creator>Bartenstein, P.</creator><creator>Stief, C. G.</creator><creator>Ilhan, H.</creator><creator>Staehler, M.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20200801</creationdate><title>PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma</title><author>Mittlmeier, L. M. ; Unterrainer, M. ; Todica, A. ; Cyran, C. C. ; Rodler, S. ; Bartenstein, P. ; Stief, C. G. ; Ilhan, H. ; Staehler, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-7a24fa2b6cfe4d37e3f8bce086fbbfae59fbec16090a3e1516ff38adabf77c0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Carcinoma, Renal Cell - diagnostic imaging</topic><topic>Carcinoma, Renal Cell - drug therapy</topic><topic>Cardiology</topic><topic>Edetic Acid</topic><topic>Enzyme inhibitors</topic><topic>Glutamate Carboxypeptidase II</topic><topic>Humans</topic><topic>Image of the Month</topic><topic>Imaging</topic><topic>Kidney cancer</topic><topic>Kidney Neoplasms - diagnostic imaging</topic><topic>Kidney Neoplasms - drug therapy</topic><topic>Kinases</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastases</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Orthopedics</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Prostatic Neoplasms</topic><topic>Radiology</topic><topic>Renal cell carcinoma</topic><topic>Tyrosine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mittlmeier, L. M.</creatorcontrib><creatorcontrib>Unterrainer, M.</creatorcontrib><creatorcontrib>Todica, A.</creatorcontrib><creatorcontrib>Cyran, C. C.</creatorcontrib><creatorcontrib>Rodler, S.</creatorcontrib><creatorcontrib>Bartenstein, P.</creatorcontrib><creatorcontrib>Stief, C. G.</creatorcontrib><creatorcontrib>Ilhan, H.</creatorcontrib><creatorcontrib>Staehler, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mittlmeier, L. M.</au><au>Unterrainer, M.</au><au>Todica, A.</au><au>Cyran, C. C.</au><au>Rodler, S.</au><au>Bartenstein, P.</au><au>Stief, C. G.</au><au>Ilhan, H.</au><au>Staehler, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>47</volume><issue>9</issue><spage>2216</spage><epage>2217</epage><pages>2216-2217</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31925458</pmid><doi>10.1007/s00259-019-04636-6</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1619-7070 |
| ispartof | European journal of nuclear medicine and molecular imaging, 2020-08, Vol.47 (9), p.2216-2217 |
| issn | 1619-7070 1619-7089 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2336256747 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Carcinoma, Renal Cell - diagnostic imaging Carcinoma, Renal Cell - drug therapy Cardiology Edetic Acid Enzyme inhibitors Glutamate Carboxypeptidase II Humans Image of the Month Imaging Kidney cancer Kidney Neoplasms - diagnostic imaging Kidney Neoplasms - drug therapy Kinases Male Medicine Medicine & Public Health Metastases Nuclear Medicine Oncology Orthopedics Positron Emission Tomography Computed Tomography Prostatic Neoplasms Radiology Renal cell carcinoma Tyrosine |
| title | PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A54%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PSMA%20PET/CT%20for%20tyrosine-kinase%20inhibitor%20monitoring%20in%20metastatic%20renal%20cell%20carcinoma&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Mittlmeier,%20L.%20M.&rft.date=2020-08-01&rft.volume=47&rft.issue=9&rft.spage=2216&rft.epage=2217&rft.pages=2216-2217&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-019-04636-6&rft_dat=%3Cproquest_cross%3E2336256747%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2420335261&rft_id=info:pmid/31925458&rfr_iscdi=true |